GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Return-on-Tangible-Asset

Cantourage Group SE (XTER:HIGH) Return-on-Tangible-Asset : 0.06% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Cantourage Group SE's annualized Net Income for the quarter that ended in Jun. 2023 was €0.03 Mil. Cantourage Group SE's average total tangible assets for the quarter that ended in Jun. 2023 was €44.88 Mil. Therefore, Cantourage Group SE's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2023 was 0.06%.

The historical rank and industry rank for Cantourage Group SE's Return-on-Tangible-Asset or its related term are showing as below:

XTER:HIGH' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -44.79   Med: -24.36   Max: 0.07
Current: 0.07

During the past 4 years, Cantourage Group SE's highest Return-on-Tangible-Asset was 0.07%. The lowest was -44.79%. And the median was -24.36%.

XTER:HIGH's Return-on-Tangible-Asset is ranked worse than
55.67% of 1085 companies
in the Drug Manufacturers industry
Industry Median: 1.6 vs XTER:HIGH: 0.07

Cantourage Group SE Return-on-Tangible-Asset Historical Data

The historical data trend for Cantourage Group SE's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE Return-on-Tangible-Asset Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Return-on-Tangible-Asset
-18.20 -44.79 -30.51 0.04

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
Return-on-Tangible-Asset Get a 7-Day Free Trial - - -0.30 0.07 0.06

Competitive Comparison of Cantourage Group SE's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's Return-on-Tangible-Asset falls into.



Cantourage Group SE Return-on-Tangible-Asset Calculation

Cantourage Group SE's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2022 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=0.009/( (4.708+44.785)/ 2 )
=0.009/24.7465
=0.04 %

Cantourage Group SE's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Jun. 2023 )  (Q: Dec. 2022 )(Q: Jun. 2023 )
=0.028/( (44.785+44.971)/ 2 )
=0.028/44.878
=0.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2023) net income data.


Cantourage Group SE  (XTER:HIGH) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Cantourage Group SE Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (XTER:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines